0.8210
+0.0025
+(0.31%)
At close: January 24 at 4:00:01 PM EST
0.8471
+0.03
+(3.18%)
After hours: January 24 at 5:11:32 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
870.7250
1,076.4050
1,375.7600
1,585.7560
903.3760
Cost of Revenue
57.4970
84.3670
138.9290
156.0800
66.3980
Gross Profit
813.2280
992.0380
1,236.8310
1,429.6760
836.9780
Operating Expense
25,490.1340
21,042.0950
16,848.4450
15,697.8090
9,797.1110
Operating Income
-24,676.9060
-20,050.0570
-15,611.6140
-14,268.1330
-8,960.1330
Other Income Expense
-122.7640
-7.2450
160.7260
-18.5220
18.5300
Pretax Income
-24,799.6700
-20,057.3020
-15,450.8880
-14,286.6550
-8,941.6030
Net Income Common Stockholders
-24,799.6700
-20,057.3020
-15,450.8880
-14,286.6550
-8,941.6030
Diluted NI Available to Com Stockholders
-24,799.6700
-20,057.3020
-15,450.8880
-14,286.6550
-8,941.6030
Basic EPS
-0.90
-1.23
-1.83
-2.24
-5.60
Diluted EPS
-0.90
-1.23
-1.83
-2.24
-5.60
Basic Average Shares
27,039.7060
16,329.7130
8,439.1770
6,370.0730
1,599.2230
Diluted Average Shares
27,039.7060
16,329.7130
8,439.1770
6,370.0730
1,599.2230
Total Operating Income as Reported
-24,688.7190
-20,050.0570
-15,621.8860
-14,290.0600
-8,961.4050
Total Expenses
25,547.6310
21,126.4620
16,987.3740
15,853.8890
9,863.5090
Net Income from Continuing & Discontinued Operation
-24,799.6700
-20,057.3020
-15,450.8880
-14,286.6550
-8,941.6030
Normalized Income
-25,379.2830
-20,050.0570
-15,611.6140
-14,268.1330
-8,960.1330
EBIT
-24,676.9060
-20,050.0570
-15,611.6140
-14,268.1330
-8,960.1330
EBITDA
-24,665.5560
-20,030.7810
-15,592.1330
-14,251.3060
-8,947.3700
Reconciled Cost of Revenue
57.4970
84.3670
138.9290
156.0800
66.3980
Reconciled Depreciation
11.3500
19.2760
19.4810
16.8270
12.7630
Net Income from Continuing Operation Net Minority Interest
-24,799.6700
-20,057.3020
-15,450.8880
-14,286.6550
-8,941.6030
Total Unusual Items Excluding Goodwill
579.6130
-7.2450
160.7260
-18.5220
18.5300
Total Unusual Items
579.6130
-7.2450
160.7260
-18.5220
18.5300
Normalized EBITDA
-25,245.1690
-20,023.5360
-15,752.8590
-14,232.7840
-8,965.9000
12/31/2020 - 5/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.8869
-5.95%
ESAIY Eisai Co., Ltd.
7.27
+1.82%
PTPI Petros Pharmaceuticals, Inc.
0.3280
-9.14%
AKAN Akanda Corp.
1.6500
-1.20%
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
13.320
+1.22%
AB.PA AB Science S.A.
1.7280
-1.37%
SOBI.ST Swedish Orphan Biovitrum AB (publ)
332.00
-1.19%
IMCC IM Cannabis Corp.
2.2100
-2.64%
ASRT Assertio Holdings, Inc.
0.8430
+4.44%
BFRI Biofrontera Inc.
1.0900
+0.06%